benzyl isothiocyanate has been researched along with erucin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, FL; Di Pasqua, AJ; Fine, RL; Govind, S; Hong, C; Mao, Y; McCracken, E; Mi, L; Tomita, Y; Wang, X; Woodrick, JC; Wu, JY | 1 |
Masuda, H; Terada, Y; Watanabe, T | 1 |
Eißmann, F; Herz, C; Lamy, E; Mersch-Sundermann, V; Münstedt, K; Oey, D; Tinneberg, HR | 1 |
3 other study(ies) available for benzyl isothiocyanate and erucin
Article | Year |
---|---|
Selective depletion of mutant p53 by cancer chemopreventive isothiocyanates and their structure-activity relationships.
Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cysteine; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Mutation; Protein Conformation; Structure-Activity Relationship; Tumor Suppressor Protein p53 | 2011 |
Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.
Topics: Animals; Armoracia; Humans; Isothiocyanates; Mice; Molecular Structure; Mustard Plant; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2015 |
Erucin and benzyl isothiocyanate suppress growth of late stage primary human ovarian carcinoma cells and telomerase activity in vitro.
Topics: Acetylcysteine; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Fragmentation; Down-Regulation; Female; G2 Phase; Humans; Isothiocyanates; Mitochondrial Membranes; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sulfides; Telomerase; Thiocyanates | 2013 |